Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M DiMichele

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 21, 2011
Haemostasis prophylaxis using single dose desmopressin acetate and extended use epsilon aminocaproic acid for adenotonsillectomy in patients with type 1 von Willebrand diseaseC Santoro, F Hsu, D M Dimichele
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
Clinical trial design in haemophiliaD M Dimichele, V Blanchette, E Berntorp
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 16, 2003
Long-term FEIBA prophylaxis does not prevent progression of existing joint diseaseM W Hilgartner, A Makipernaa, D M Dimichele
Journal of Thrombosis and Haemostasis : JTH|March 6, 2004
Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemiasS S Acharya, A Coughlin, D M Dimichele, et al.
Journal of Pediatric Hematology/Oncology|May 1, 1996
Management of an acute hemorrhagic ovarian cyst in a female patient with hemophilia AP M O'Brien, D M DiMichele, D O Walterhouse
American Journal of Hematology|February 1, 1996
In vitro factor VIII recovery during the delivery of ultrapure factor VIII concentrate by continuous infusionD M DiMichele, M E Lasak, C H Miller
Journal of Thrombosis and Haemostasis : JTH|March 3, 2015
Design of clinical trials for new products in hemophilia: communication from the SSC of the ISTHD M Dimichele, S Lacroix-Desmazes, F Peyvandi, et al.
American Journal of Hematology|September 1, 1994
Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia A patients with inhibitorsM L Schmidt, S Gamerman, H E Smith, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 27, 2003
Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infectionD M DiMichele, G Mirani, P Wilfredo Canchis, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 18, 2007
The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profileD A Greninger, J M Saint-Remy, M Jacquemin, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 21, 2011
Haemostasis prophylaxis using single dose desmopressin acetate and extended use epsilon aminocaproic acid for adenotonsillectomy in patients with type 1 von Willebrand diseaseC Santoro, F Hsu, D M Dimichele
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
Clinical trial design in haemophiliaD M Dimichele, V Blanchette, E Berntorp
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 16, 2003
Long-term FEIBA prophylaxis does not prevent progression of existing joint diseaseM W Hilgartner, A Makipernaa, D M Dimichele
Journal of Thrombosis and Haemostasis : JTH|March 6, 2004
Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemiasS S Acharya, A Coughlin, D M Dimichele, et al.
Journal of Pediatric Hematology/Oncology|May 1, 1996
Management of an acute hemorrhagic ovarian cyst in a female patient with hemophilia AP M O'Brien, D M DiMichele, D O Walterhouse
American Journal of Hematology|February 1, 1996
In vitro factor VIII recovery during the delivery of ultrapure factor VIII concentrate by continuous infusionD M DiMichele, M E Lasak, C H Miller
Journal of Thrombosis and Haemostasis : JTH|March 3, 2015
Design of clinical trials for new products in hemophilia: communication from the SSC of the ISTHD M Dimichele, S Lacroix-Desmazes, F Peyvandi, et al.
American Journal of Hematology|September 1, 1994
Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia A patients with inhibitorsM L Schmidt, S Gamerman, H E Smith, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 27, 2003
Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infectionD M DiMichele, G Mirani, P Wilfredo Canchis, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 18, 2007
The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profileD A Greninger, J M Saint-Remy, M Jacquemin, et al.
Pageof 4